These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15871681)

  • 1. Elements of style: consent form language and the therapeutic misconception in phase 1 gene transfer trials.
    Kimmelman J; Levenstadt A
    Hum Gene Ther; 2005 Apr; 16(4):502-8. PubMed ID: 15871681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis.
    Kimmelman J; Palmour N
    J Med Ethics; 2005 Apr; 31(4):209-14. PubMed ID: 15800361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consent forms and the therapeutic misconception: the example of gene transfer research.
    King NM; Henderson GE; Churchill LR; Davis AM; Hull SC; Nelson DK; Parham-Vetter PC; Rothschild BB; Easter MM; Wilfond BS
    IRB; 2005; 27(1):1-8. PubMed ID: 15835063
    [No Abstract]   [Full Text] [Related]  

  • 4. Uncertain benefit: investigators' views and communications in early phase gene transfer trials.
    Henderson GE; Davis AM; King NM; Easter MM; Zimmer CR; Rothschild BB; Wilfond BS; Nelson DK; Churchill LR
    Mol Ther; 2004 Aug; 10(2):225-31. PubMed ID: 15294169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic misconception in early phase gene transfer trials.
    Henderson GE; Easter MM; Zimmer C; King NM; Davis AM; Rothschild BB; Churchill LR; Wilfond BS; Nelson DK
    Soc Sci Med; 2006 Jan; 62(1):239-53. PubMed ID: 16000230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of informed consent for in utero gene transfer research: implications for investigators and institutional review boards.
    Burger IM; Wilfond BS
    Hum Gene Ther; 2000 May; 11(7):1057-63. PubMed ID: 10811234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptions of benefits and risks in consent forms for phase 1 oncology trials.
    Horng S; Emanuel EJ; Wilfond B; Rackoff J; Martz K; Grady C
    N Engl J Med; 2002 Dec; 347(26):2134-40. PubMed ID: 12501226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed consent in human gene transfer clinical trials.
    Kahn J
    Hum Gene Ther; 2008 Jan; 19(1):7-8. PubMed ID: 18211226
    [No Abstract]   [Full Text] [Related]  

  • 9. Confronting the issues of therapeutic misconception, enrollment decisions, and personal motives in genetic medicine-based clinical research studies for fatal disorders.
    Arkin LM; Sondhi D; Worgall S; Suh LH; Hackett NR; Kaminsky SM; Hosain SA; Souweidane MM; Kaplitt MG; Dyke JP; Heier LA; Ballon DJ; Shungu DC; Wisniewski KE; Greenwald BM; Hollmann C; Crystal RG
    Hum Gene Ther; 2005 Sep; 16(9):1028-36. PubMed ID: 16149901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moral justification of Phase 1 oncology trials.
    Dubov A
    J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):138-51. PubMed ID: 24813655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Therapeutic misconception" and "recruiting doublespeak" in the informed consent process.
    Hochhauser M
    IRB; 2002; 24(1):11-2. PubMed ID: 14509292
    [No Abstract]   [Full Text] [Related]  

  • 12. Beyond informed consent: the therapeutic misconception and trust.
    de Melo-Martín I; Ho A
    J Med Ethics; 2008 Mar; 34(3):202-5. PubMed ID: 18316464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism.
    Horng S; Grady C
    IRB; 2003; 25(1):11-6. PubMed ID: 12833900
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic discourse among nurses and physicians in controlled clinical trials.
    Instone SL; Mueller MR; Gilbert TL
    Nurs Ethics; 2008 Nov; 15(6):803-12. PubMed ID: 18849369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic misconception, beneficence, and respect.
    Fried E
    Account Res; 2001; 8(4):331-48. PubMed ID: 12481794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?
    Miller FG; Joffe S
    Clin Trials; 2008; 5(6):617-23. PubMed ID: 19029210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rewriting the "points to consider": the ethical impact of guidance document language.
    King NM
    Hum Gene Ther; 1999 Jan; 10(1):133-9. PubMed ID: 10022538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ethics of phase 0 oncology trials.
    Abdoler E; Taylor H; Wendler D
    Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trust, The fragile foundation of contemporary biomedical research.
    Kass NE; Sugarman J; Faden R; Schoch-Spana M
    Hastings Cent Rep; 1996; 26(5):25-9. PubMed ID: 8891706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.